GGrantIndex
← Leaderboards

Colleen E Clancy

Weill Medical Coll Of Cornell Univ

$12,823,774
Attributed
$25,319,788
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,319,788 · 8

By mechanism

R01$15,753,807 · 6
OT2$5,716,980 · 1
U01$3,849,001 · 1

Most similar at Weill Medical Coll Of Cornell Univ

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsPharmaceutical PreparationsCardiacIon ChannelArrhythmiaBaseComplexMolecularTissuesVoltageSimulationPhysiologicalLinkPropertyVirtualKineticsResearch PersonnelMolecular ConformationDrug InteractionsHeartBehaviorResponseMulti-Scale ModelingHeart Rhythm

Grant awards (37)

Digital Twins from the Atom to the Rhythm$791,630
R01 · FY2025 · HL · contact PI
Metabolic Control of Cardiac Pacemaking$635,224
R01 · FY2025 · HL
Digital Twins from the Atom to the Rhythm$790,432
R01 · FY2024 · HL · contact PI
In silico safety pharmacology$694,248
R01 · FY2024 · HL · contact PI
Metabolic Control of Cardiac Pacemaking$635,224
R01 · FY2024 · HL
In silico safety pharmacology$726,367
R01 · FY2023 · HL · contact PI
Multi-Scale Modeling of Vascular Signaling Units$545,332
R01 · FY2023 · HL
In silico safety pharmacology$720,886
R01 · FY2022 · HL · contact PI
Multi-Scale Modeling of Vascular Signaling Units$545,332
R01 · FY2022 · HL
Development of the Predictive NeuroCardiovascular Simulator$1,498,542
OT2 · FY2021 · OD · contact PI
In silico safety pharmacology$725,146
R01 · FY2021 · HL · contact PI
Multi-Scale Modeling of Vascular Signaling Units$545,332
R01 · FY2021 · HL
Multi-Scale Modeling of Vascular Signaling Units$227,336
R01 · FY2021 · HL
Development of the Predictive NeuroCardiovascular Simulator$1,450,692
OT2 · FY2020 · OD · contact PI
Development of the Predictive NeuroCardiovascular Simulator$691,874
OT2 · FY2020 · OD · contact PI
Multi-Scale Modeling of Vascular Signaling Units$545,332
R01 · FY2020 · HL
Predictive multiscale in silico cardio-pharmacology$771,846
U01 · FY2019 · HL · contact PI
In silico Safety Pharmacology$697,903
R01 · FY2019 · HL · contact PI
Development of the Predictive NeuroCardiovascular Simulator$691,875
OT2 · FY2019 · OD · contact PI
Development of the Predictive NeuroCardiovascular Simulator$1,383,997
OT2 · FY2018 · OD · contact PI
Predictive multiscale in silico cardio-pharmacology$786,091
U01 · FY2018 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$730,325
R01 · FY2018 · HL
In silico Safety Pharmacology$675,851
R01 · FY2018 · HL · contact PI
Predictive multiscale in silico cardio-pharmacology$749,824
U01 · FY2017 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$746,125
R01 · FY2017 · HL
In silico Safety Pharmacology$688,741
R01 · FY2017 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$758,646
R01 · FY2016 · HL
Predictive multiscale in silico cardio-pharmacology$751,173
U01 · FY2016 · HL · contact PI
In silico Safety Pharmacology$739,652
R01 · FY2016 · HL · contact PI
Predictive multiscale in silico cardio-pharmacology$790,067
U01 · FY2015 · HL · contact PI
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling$786,927
R01 · FY2015 · HL
Pharmacogenomics and antiarrhythmic therapy: An in silico investigation$306,750
R01 · FY2011 · HL · contact PI
Pharmacogenomics and antiarrhythmic therapy: An in silico investigation$306,000
R01 · FY2010 · HL · contact PI
Pharmacogenomics and antiarrhythmic therapy: An in silico investigation$336,000
R01 · FY2009 · HL · contact PI
Pharmacogenomics and antiarrhythmic therapy: An in silico investigation$181,066
R01 · FY2009 · HL · contact PI
Pharmacogenomics and antiarrhythmic therapy: An in silico investigation$336,000
R01 · FY2008 · HL · contact PI
Pharmacogenomics and antiarrhythmic therapy: An in silico investigation$336,000
R01 · FY2007 · HL · contact PI